‘Better treatments’: Government to fund psychedelic drugs trials to treat mental illness

Fungi containing psilocybin - otherwise known as magic mushrooms - will be part of government-funded trials into mental health treatments.

Clinical trials using magic mushrooms, ecstasy and other psychedelic drugs in potential breakthrough therapies for debilitating mental illnesses will be funded by the federal government as part of global efforts to advance innovative treatments. There is growing international evidence showing substances such as ketamine, psilocybin and MDMA can successfully treat resistant mental illnesses, including depression and post-traumatic stress disorder, when used in a controlled environment and supported by psychiatric care.

‘Better treatments’: Government to fund psychedelic drugs trials to treat mental illness